...
首页> 外文期刊>Techniques in vascular and interventional radiology >Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants
【24h】

Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants

机译:肺栓塞中的抗凝:直接口服抗凝剂的年龄更新

获取原文
获取原文并翻译 | 示例
           

摘要

The emergence of direct oral anticoagulants (DOACs) represents a major advancement and paradigm shift in the treatment of venous thromboembolism. Currently, dabigatran, rivaroxaban, apixiban, and edoxoban are approved and used routinely for the prevention and treatment of patients with venous thromboembolism. Because each of the DOACs has different doses and dosing regimens, clinicians need to become familiar with their use. This article focuses on the practical considerations of how and when to use the DOACs. It also aims to explore follow-up monitoring, use in special populations, reversal agents, periprocedural management, and how to handle bleeding complications with the DOACs.]]>
机译:]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号